These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31846162)

  • 1. Atypical anti-p200 pemphigoid with nail involvement and blisters over the joints.
    Horváth ON; Bagci IS; Ruzicka T; Sárdy M
    J Dtsch Dermatol Ges; 2019 Dec; 17(12):1289-1290. PubMed ID: 31846162
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
    Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
    JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
    García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
    Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-p200 pemphigoid: clinical, diagnostic and therapeutic aspects].
    Drerup KA; Wehkamp U
    Hautarzt; 2020 Feb; 71(2):130-133. PubMed ID: 31501972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
    Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
    Raffin D; Delaplace M; Roussel A; Estève E
    Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
    Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence of the nail bed in pemphigoid.
    Barth JH; Wojnarowska F; Millard PR; Dawber RP
    Am J Dermatopathol; 1987 Aug; 9(4):349-50. PubMed ID: 3307480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-p200 pemphigoid].
    Holtsche MM; Goletz S; Zillikens D
    Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-p200 pemphigoid: a spectacular response to dapsone].
    Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
    Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous pemphigoid with permanent loss of the nails.
    Namba Y; Koizumi H; Kumakiri M; Hashimoto T; Muramatsu T; Ohkawara A
    Acta Derm Venereol; 1999 Nov; 79(6):480-1. PubMed ID: 10598770
    [No Abstract]   [Full Text] [Related]  

  • 13. Case of anti-p200 pemphigoid accompanying uterine malignancy.
    Hayashi M; Okamura K; Ujiie H; Iwata H; Suzuki T
    J Dermatol; 2018 Dec; 45(12):e341-e342. PubMed ID: 29766559
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoglobulin G deposition to nonhemidesmosomal lamina lucida and early neutrophil involvement are characteristic features in a case of anti-p200 pemphigoid.
    Shimizu A; Funakoshi T; Ishibashi M; Yoshida T; Koga H; Hashimoto T; Amagai M; Ishiko A
    Br J Dermatol; 2013 Mar; 168(3):647-55. PubMed ID: 22963596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An attempt to develop mouse model for anti-laminin γ1 pemphigoid.
    Koga H; Ishii N; Dainichi T; Tsuruta D; Hamada T; Ohata C; Karashima T; Furumura M; Hashimoto T
    J Dermatol Sci; 2013 May; 70(2):108-15. PubMed ID: 23410740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-laminin 5 pemphigoid and acquired haemophilia.
    Ly A; Roth B; Causeret AS; Jullien D; Kanitakis J; Faure M; Claudy A
    Br J Dermatol; 2002 Jun; 146(6):1104-5. PubMed ID: 12072091
    [No Abstract]   [Full Text] [Related]  

  • 17. Serologic characterization of anti-p200 pemphigoid: Epitope spreading as a common phenomenon.
    Holtsche MM; Goletz S; von Georg A; van Beek N; Hübner F; Pigors M; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2021 Apr; 84(4):1155-1157. PubMed ID: 32711089
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-p200 pemphigoid.
    Goletz S; Hashimoto T; Zillikens D; Schmidt E
    J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
    Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
    Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-p200 Pemphigoid: A Systematic Review.
    Kridin K; Ahmed AR
    Front Immunol; 2019; 10():2466. PubMed ID: 31695695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.